After “careful analysis”, AstraZeneca says “there is no evidence that the vaccine increases the risk of blood clots”

The company says it has carried out a “careful analysis” of the data available on people who have received the AstraZeneca vaccine in the United Kingdom and the European Union.

“About 17 million people in the European Union and the United Kingdom have now received our vaccine, and the number of blood clot cases reported in this group is lower than the hundreds of cases one would expect in the general population “said Medical Director Ann Taylor.

“The nature of the pandemic has led to an increased focus on individual cases,” she added.

According to the European Medicines Agency (EMA), there is no evidence of a risk of increased blood clotting in people vaccinated against Covid-19. The information available to date also indicates that the number of thromboembolisms in vaccinated people is not higher than that observed in the entire population, she said Thursday.

The World Health Organization (WHO) also says there is no cause for concern.